As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial

MLA

Thongngarm, Torpong, et al. “As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial.” The Journal of Allergy and Clinical Immunology: In Practice, vol. 9, no. 3, Mar. 2021, p. 1365–1373.e6. EBSCOhost, https://doi.org/10.1016/j.jaip.2020.09.057.

APA

Thongngarm, T., Wongsa, C., Phinyo, P., Assanasen, P., Tantilipikorn, P., & Sompornrattanaphan, M. (2021). As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial. The Journal of Allergy and Clinical Immunology: In Practice, 9(3), 1365–1373.e6. https://doi.org/10.1016/j.jaip.2020.09.057

Chicago

Thongngarm, Torpong, Chamard Wongsa, Phichayut Phinyo, Paraya Assanasen, Pongsakorn Tantilipikorn, and Mongkhon Sompornrattanaphan. 2021. “As-Needed Versus Regular Use of Fluticasone Furoate Nasal Spray in Patients with Moderate to Severe, Persistent, Perennial Allergic Rhinitis: A Randomized Controlled Trial.” The Journal of Allergy and Clinical Immunology: In Practice 9 (3): 1365–1373.e6. doi:10.1016/j.jaip.2020.09.057.